Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Lomustine × 1 year × Clear all

Phase

Phase 2 8 Phase 3 7 Phase 2/3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Recurrence 1 Glioblastoma 1

Interventions

pembrolizumab 24 Cisplatin 23 Carboplatin 17 Magnetic Resonance Spectroscopy 15 Gemcitabine 15 Oxaliplatin 14 Drug Therapy 14 Paclitaxel 12 Nivolumab 12 atezolizumab 11 Specimen Handling 11 Capecitabine 11 Bevacizumab 11 Doxorubicin 10 Dexamethasone 10 Radiotherapy 9 Pemetrexed 9 Fluorouracil 9 Cyclophosphamide 9 venetoclax 8 Radiation 8 Ipilimumab 8 Docetaxel 8 Trastuzumab 7 Prednisone 7 Leucovorin 7 Cytarabine 7 Vincristine 6 Temozolomide 6 Taxes 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03970447 2025-09-09

GBM AGILE

Global Coalition for Adaptive Research

Phase 2/3 Recruiting

Glioblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡